» Articles » PMID: 28344743

The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer?

Overview
Date 2017 Mar 28
PMID 28344743
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

The abscopal effect refers to the ability of localized radiation to trigger systemic antitumor effects. Over the past 50 years, reports on the abscopal effect arising from conventional radiation have been relatively rare. However, with the continued development and use of immunotherapy strategies incorporating radiotherapy with targeted immunomodulators and immune checkpoint blockade, the abscopal effect is becoming increasingly relevant in less immunogenic tumors such as breast cancer. Here, we review the mechanism of the abscopal effect, the current preclinical and clinical data, and the application of the abscopal effect in designing clinical trials of immunotherapy combined with radiotherapy in breast cancer.

Citing Articles

The Synergy of Thermal and Non-Thermal Effects in Hyperthermic Oncology.

Minnaar C, Szigeti G, Szasz A Cancers (Basel). 2024; 16(23).

PMID: 39682096 PMC: 11639953. DOI: 10.3390/cancers16233908.


Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy.

Wang X, Zhang H, XinZhang , Liu Y Biomark Res. 2024; 12(1):98.

PMID: 39228005 PMC: 11373306. DOI: 10.1186/s40364-024-00628-3.


Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy.

Winter R, Amghar M, Wacker A, Bakos G, Tas H, Roscher M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204136 PMC: 11359268. DOI: 10.3390/ph17081031.


Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions.

Ser M, Webb M, Sener U, Campian J J Immunother Precis Oncol. 2024; 7(2):97-110.

PMID: 38721406 PMC: 11075475. DOI: 10.36401/JIPO-23-34.


Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.

Reilly R, Georgiou C, Brown M, Cai Z EJNMMI Radiopharm Chem. 2024; 9(1):37.

PMID: 38703297 PMC: 11069497. DOI: 10.1186/s41181-024-00266-y.


References
1.
Pasare C, Medzhitov R . Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005; 560:11-8. DOI: 10.1007/0-387-24180-9_2. View

2.
Grilli G, NOTHDURFT W, FLIEDNER T . Radiation sensitivity of human erythropoietic and granulopoietic progenitor cells in the blood and in the bone marrow. Int J Radiat Biol Relat Stud Phys Chem Med. 1982; 41(6):685-7. DOI: 10.1080/09553008214550781. View

3.
Andersson U, Wang H, Palmblad K, Aveberger A, Bloom O, Erlandsson-Harris H . High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med. 2000; 192(4):565-70. PMC: 2193240. DOI: 10.1084/jem.192.4.565. View

4.
Ruocco M, Pilones K, Kawashima N, Cammer M, Huang J, Babb J . Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects. J Clin Invest. 2012; 122(10):3718-30. PMC: 3461908. DOI: 10.1172/JCI61931. View

5.
Slovin S, Higano C, Hamid O, Tejwani S, Harzstark A, Alumkal J . Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study. Ann Oncol. 2013; 24(7):1813-1821. PMC: 3707423. DOI: 10.1093/annonc/mdt107. View